Email not displaying correctly? View it in your browser
SciTech Patent Art Services & Global IP Services LLC.

On April 30, 2010, the Chennai Patent Office rejected M/s Hoffman-La Roche AG’s patent for the crucial HIV drug, Valgancyclovir.
As most of us have begun to realize, the rejection raises questions with respect to several crucial issues, including post-grant opposition, inventive step and the efficacy requirement.

 

In this Webinar, the implications of this judgement will be dealt by two experts on the subject- Dr. Srividhya Ragavan and Mr. Feroz Ali.

 
About the Speakers:
Dr. Srividhya who is a Professor of Law at the University of Oklahoma College of Law, currently serving as a visiting Professor at The National Law School, Bangalore, was the first to write on the Roche patent opposition in Livemint where she regularly writes on law, technology and intellectual property issues. read more>>
Mr. Feroz Ali is a well known Indian intellectual property expert and is one of the Counsels for the opponents in this post-grant hearing. His earlier book was a treatise on the Indian patent law with a focus on pharmaceuticals. His latest book focuses on the pre-grant opposition mechanism in India and how it could be used effectively in business.
@2010 SciTech Patent Art Services. All rights reserved.